Stem cell biology and therapeutic applications
- 1 July 2003
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Nephrology and Hypertension
- Vol. 12 (4) , 447-454
- https://doi.org/10.1097/00041552-200307000-00014
Abstract
Chronic diseases are common and deadly. Stem cell therapies have received intense interest for the repopulation of damaged or diseased tissues. A detailed understanding of the similarities and differences between embryonic stem cells and somatic stem cells will enhance our understanding of mechanisms of tissue repair or cellular augmentation. In addition, emerging technologies will be useful in the definition of the molecular regulation of the respective stem cell populations. A number of postnatal tissues have a population of somatic stem cells, which function in the maintenance and repair of tissues. Using molecular technologies these somatic stem cell populations have been shown to be pluripotent when placed in a permissive environment. Recent studies have utilized emerging technologies to define a molecular signature of embryonic stem cells and selected somatic stem cell populations. These strategies will be useful for the definition of a molecular program that promotes a stem cell phenotype (i.e. stemness phenotype). Recent studies suggest that embryonic and somatic stem cell populations hold promise as sources for tissue engineering. The use of cell biological and molecular technologies will enhance our understanding of embryonic and somatic stem cell populations and their molecular regulatory events that promote multipotentiation.Keywords
This publication has 51 references indexed in Scilit:
- Prevalence, Expenditures, and Complications of Multiple Chronic Conditions in the ElderlyArchives of internal medicine (1960), 2002
- Stem Cells from the Mammalian BlastocystThe International Journal of Cell Cloning, 2001
- Strategies for Making More Organs Available for TransplantationNew England Journal of Medicine, 2000
- Translating Stem and Progenitor Cell Biology to the Clinic: Barriers and OpportunitiesScience, 2000
- Stem CellsCell, 2000
- Stem CellsCell, 2000
- Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genesNature, 1988
- Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cellsCell, 1987
- Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells.Proceedings of the National Academy of Sciences, 1981
- Establishment in culture of pluripotential cells from mouse embryosNature, 1981